Phibro Animal Health Corporation (PAHC)
Working capital turnover
Jun 30, 2024 | Jun 30, 2023 | Jun 30, 2022 | Jun 30, 2021 | Jun 30, 2020 | ||
---|---|---|---|---|---|---|
Revenue | US$ in thousands | 993,816 | 960,113 | 935,602 | 833,350 | 800,354 |
Total current assets | US$ in thousands | 600,997 | 585,723 | 566,232 | 498,909 | 451,837 |
Total current liabilities | US$ in thousands | 204,148 | 176,000 | 190,832 | 164,116 | 157,238 |
Working capital turnover | 2.50 | 2.34 | 2.49 | 2.49 | 2.72 |
June 30, 2024 calculation
Working capital turnover = Revenue ÷ (Total current assets – Total current liabilities)
= $993,816K ÷ ($600,997K – $204,148K)
= 2.50
The working capital turnover ratio for Phibro Animal Health Corporation has shown a relatively stable trend over the past five years. The ratio provides insight into how efficiently the company is utilizing its working capital to generate revenue.
In 2024, the working capital turnover ratio stands at 2.50, indicating that for every dollar of working capital invested, the company generates $2.50 of revenue. This suggests that Phibro Animal Health Corporation has improved its efficiency in utilizing its working capital compared to the prior year.
While the ratio decreased slightly in 2023 to 2.34, it rebounded in 2024 to 2.50. This indicates that the company has managed to enhance its operational efficiency in utilizing its current assets and liabilities to drive revenue.
Looking at the trend over the five-year period, the working capital turnover ratio has been relatively consistent, ranging from 2.34 to 2.72. This stability suggests that Phibro Animal Health Corporation has maintained a consistent level of efficiency in managing its working capital over the years.
Overall, the working capital turnover ratio for Phibro Animal Health Corporation reflects a consistent and efficient use of working capital to generate revenue, indicating a healthy financial performance in terms of working capital management.
Peer comparison
Jun 30, 2024